Banner deployed by MSF in front of the World Trade Organization (WTO) in Geneva calling on certain governments to stop blocking the landmark waiver proposal on intellectual property (IP) during the pandemic.
Statement |

MSF feedback on EU statement at WTO COVID-19 vaccine equity event

Banner deployed by MSF in front of the World Trade Organization (WTO) in Geneva calling on certain governments to stop blocking the landmark waiver proposal on intellectual property (IP) during the pandemic.

In their statement at a recent virtual event titled "COVID-19 and Vaccine Equity: What Can the WTO Contribute?" held on 14 April 2021, the European Union (EU) Commission continued to defend a position that leaves a handful of pharmaceutical companies strongly in control of global production and supply of the vaccines. The EU bloc is one of the few remaining voices still blocking the so-called TRIPS Waiver, which could increase global access to COVID-19 medical tools.

Our team has annotated the statement to analyse the EU's arguments.

MSF comments on the EU's statement by the MSF Access Campaign team